August 7, 2026 · Form 4 insider transaction
Garcia Marino bought 40,000 shares of Dianthus Therapeutics, Inc. at $8.44 per share, a transaction worth $337.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.